{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T20:08:59Z","timestamp":1787170139638,"version":"build-2736575974"},"reference-count":80,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,6,3]],"date-time":"2022-06-03T00:00:00Z","timestamp":1654214400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,6,3]],"date-time":"2022-06-03T00:00:00Z","timestamp":1654214400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"crossref","award":["PR 1725\/2-1"],"award-info":[{"award-number":["PR 1725\/2-1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["RU 2169\/2-1"],"award-info":[{"award-number":["RU 2169\/2-1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003042","name":"Else Kr\u00f6ner-Fresenius-Stiftung","doi-asserted-by":"publisher","award":["2018_A03"],"award-info":[{"award-number":["2018_A03"]}],"id":[{"id":"10.13039\/501100003042","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Federeal Ministry of Education and Research","award":["01EC1901A"],"award-info":[{"award-number":["01EC1901A"]}]},{"name":"Deutsche Gesellschaft f\u00fcr Muskelerkrankte","award":["Ru2\/1"],"award-info":[{"award-number":["Ru2\/1"]}]},{"name":"Deutsche Gesellschaft f\u00fcr Muskelerkrankte","award":["Sc22\/4"],"award-info":[{"award-number":["Sc22\/4"]}]},{"name":"Deutsche Gesellschaft f\u00fcr Muskelerkrankte e.V.","award":["Ne4\/1"],"award-info":[{"award-number":["Ne4\/1"]}]},{"DOI":"10.13039\/501100002839","name":"Charit\u00e9 - Universit\u00e4tsmedizin Berlin","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100002839","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["acta neuropathol commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Inclusion body myositis (IBM) is the most prevalent idiopathic inflammatory myopathy (IIM) affecting older adults. The pathogenic hallmark of IBM is chronic inflammation of skeletal muscle. At present, we do not classify IBM into different sub-entities, with the exception perhaps being the presence or absence of the anti-cN-1A-antibody. In contrast to other IIM, IBM is characterized by a chronic and progressive disease course. Here, we discuss the pathophysiological framework of IBM and highlight the seemingly prototypical situations where IBM occurs in the context of other diseases. In this context, understanding common immune pathways might provide insight into the pathogenesis of IBM. Indeed, IBM is associated with a distinct set of conditions, such as human immunodeficiency virus (HIV) or hepatitis C\u2014two conditions associated with premature immune cell exhaustion. Further, the pathomorphology of IBM is reminiscent of other muscle diseases, notably HIV-associated myositis or granulomatous myositis. Distinct immune pathways are likely to drive these commonalities and senescence of the CD8\n                    <jats:sup>+<\/jats:sup>\n                    T cell compartment is discussed as a possible mechanism of pathogenesis. Future effort directed at understanding the co-occurrence of IBM and associated diseases could prove valuable to better understand the enigmatic IBM pathophysiology.\n                  <\/jats:p>","DOI":"10.1186\/s40478-022-01389-6","type":"journal-article","created":{"date-parts":[[2022,6,3]],"date-time":"2022-06-03T06:03:45Z","timestamp":1654236225000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":33,"title":["Inclusion body myositis and associated diseases: an argument for shared immune pathologies"],"prefix":"10.1186","volume":"10","author":[{"given":"Christopher","family":"Nelke","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felix","family":"Kleefeld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corinna","family":"Preusse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobias","family":"Ruck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1143-2103","authenticated-orcid":false,"given":"Werner","family":"Stenzel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,6,3]]},"reference":[{"key":"1389_CR1","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.nmd.2018.10.007","volume":"29","author":"RM Alhammad","year":"2019","unstructured":"Alhammad RM, Liewluck T (2019) Myopathies featuring non-caseating granulomas: sarcoidosis, inclusion body myositis and an unfolding overlap. Neuromuscul Disord NMD 29:39\u201347. https:\/\/doi.org\/10.1016\/j.nmd.2018.10.007","journal-title":"Neuromuscul Disord NMD"},{"key":"1389_CR2","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1002\/ana.410230210","volume":"23","author":"K Arahata","year":"1988","unstructured":"Arahata K, Engel AG (1988) Monoclonal antibody analysis of mononuclear cells in myopathies. IV: cell-mediated cytotoxicity and muscle fiber necrosis. Ann Neurol 23:168\u2013173. https:\/\/doi.org\/10.1002\/ana.410230210","journal-title":"Ann Neurol"},{"key":"1389_CR3","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000000452","author":"FC Aubart","year":"2018","unstructured":"Aubart FC, Abbara S, Maisonobe T, Cottin V, Papo T, Haroche J, Mathian A, Pha M, Gilardin L, Hervier B, Soussan M, Morlat P, Nunes H, Benveniste O, Amoura Z, Valeyre D (2018) Symptomatic muscular sarcoidosis: lessons from a nationwide multicenter study. Neurol - Neuroimmunol Neuroinflam. https:\/\/doi.org\/10.1212\/NXI.0000000000000452","journal-title":"Neurol - Neuroimmunol Neuroinflam"},{"key":"1389_CR4","doi-asserted-by":"publisher","first-page":"554","DOI":"10.3389\/fneur.2019.00554","volume":"10","author":"O Benveniste","year":"2019","unstructured":"Benveniste O, Goebel H-H, Stenzel W (2019) Biomarkers in inflammatory myopathies\u2014an expanded definition. Front Neurol 10:554. https:\/\/doi.org\/10.3389\/fneur.2019.00554","journal-title":"Front Neurol"},{"key":"1389_CR5","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1097\/WCO.0000000000000376","volume":"29","author":"O Benveniste","year":"2016","unstructured":"Benveniste O, Stenzel W, Allenbach Y (2016) Advances in serological diagnostics of inflammatory myopathies. Curr Opin Neurol 29:662\u2013673. https:\/\/doi.org\/10.1097\/WCO.0000000000000376","journal-title":"Curr Opin Neurol"},{"key":"1389_CR6","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1007\/s00401-015-1384-5","volume":"129","author":"O Benveniste","year":"2015","unstructured":"Benveniste O, Stenzel W, Hilton-Jones D, Sandri M, Boyer O, van Engelen BGM (2015) Amyloid deposits and inflammatory infiltrates in sporadic inclusion body myositis: the inflammatory egg comes before the degenerative chicken. Acta Neuropathol (Berl) 129:611\u2013624. https:\/\/doi.org\/10.1007\/s00401-015-1384-5","journal-title":"Acta Neuropathol (Berl)"},{"key":"1389_CR7","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.clim.2007.08.015","volume":"126","author":"A Boasso","year":"2008","unstructured":"Boasso A, Shearer GM (2008) Chronic innate immune activation as a cause of HIV-1 immunopathogenesis. Clin Immunol Orlando Fla 126:235\u2013242. https:\/\/doi.org\/10.1016\/j.clim.2007.08.015","journal-title":"Clin Immunol Orlando Fla"},{"key":"1389_CR8","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2013-004552","volume":"4","author":"S Brady","year":"2014","unstructured":"Brady S, Squier W, Sewry C, Hanna M, Hilton-Jones D, Holton JL (2014) A retrospective cohort study identifying the principal pathological features useful in the diagnosis of inclusion body myositis. BMJ Open 4:e004552. https:\/\/doi.org\/10.1136\/bmjopen-2013-004552","journal-title":"BMJ Open"},{"key":"1389_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/nrdp.2016.47","volume":"2","author":"P Brito-Zer\u00f3n","year":"2016","unstructured":"Brito-Zer\u00f3n P, Baldini C, Bootsma H, Bowman SJ, Jonsson R, Mariette X, Sivils K, Theander E, Tzioufas A, Ramos-Casals M (2016) Sj\u00f6gren syndrome. Nat Rev Dis Primer 2:1\u201320. https:\/\/doi.org\/10.1038\/nrdp.2016.47","journal-title":"Nat Rev Dis Primer"},{"key":"1389_CR10","doi-asserted-by":"publisher","first-page":"eabi196","DOI":"10.1126\/scitranslmed.abi9196","volume":"14","author":"KA Britson","year":"2022","unstructured":"Britson KA, Ling JP, Braunstein KE, Montagne JM, Kastenschmidt JM, Wilson A, Ikenaga C, Tsao W, Pinal-Fernandez I, Russell KA, Reed N, Mozaffar T, Wagner KR, Ostrow LW, Corse AM, Mammen AL, Villalta SA, Larman HB, Wong PC, Lloyd TE (2022) Loss of TDP-43 function and rimmed vacuoles persist after T cell depletion in a xenograft model of sporadic inclusion body myositis. Sci Transl Med 14:eabi196. https:\/\/doi.org\/10.1126\/scitranslmed.abi9196","journal-title":"Sci Transl Med"},{"key":"1389_CR11","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/j.radcr.2020.12.014","volume":"16","author":"TVR Burr","year":"2021","unstructured":"Burr TVR, Kazan-Tannus JF (2021) Myositis and myopathy of sarcoidosis: a case report. Radiol Case Rep 16:433\u2013437. https:\/\/doi.org\/10.1016\/j.radcr.2020.12.014","journal-title":"Radiol Case Rep"},{"key":"1389_CR12","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1212\/WNL.28.1.8","volume":"28","author":"S Carpenter","year":"1978","unstructured":"Carpenter S, Karpati G, Heller I, Eisen A (1978) Inclusion body myositis: a distinct variety of idiopathic inflammatory myopathy. Neurology 28:8\u20138. https:\/\/doi.org\/10.1212\/WNL.28.1.8","journal-title":"Neurology"},{"key":"1389_CR13","doi-asserted-by":"publisher","first-page":"200","DOI":"10.3389\/fcell.2020.00200","volume":"8","author":"G Chen","year":"2020","unstructured":"Chen G, Kroemer G, Kepp O (2020) Mitophagy: an emerging role in aging and age-associated diseases. Front Cell Dev Biol 8:200. https:\/\/doi.org\/10.3389\/fcell.2020.00200","journal-title":"Front Cell Dev Biol"},{"key":"1389_CR14","first-page":"457","volume":"33","author":"S Colafrancesco","year":"2015","unstructured":"Colafrancesco S, Priori R, Gattamelata A, Picarelli G, Minniti A, Brancatisano F, D\u2019Amati G, Giordano C, Cerbelli B, Maset M, Quartuccio L, Bartoloni E, Carubbi F, Cipriani P, Baldini C, Luciano N, De Vita S, Gerli R, Giacomelli R, Bombardieri S, Valesini G (2015) Myositis in primary Sj\u00f6gren\u2019s syndrome: data from a multicentre cohort. Clin Exp Rheumatol 33:457\u2013464","journal-title":"Clin Exp Rheumatol"},{"key":"1389_CR15","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1056\/NEJM199004193221602","volume":"322","author":"MC Dalakas","year":"1990","unstructured":"Dalakas MC, Illa I, Pezeshkpour GH, Laukaitis JP, Cohen B, Griffin JL (1990) Mitochondrial myopathy caused by long-term zidovudine therapy. N Engl J Med 322:1098\u20131105. https:\/\/doi.org\/10.1056\/NEJM199004193221602","journal-title":"N Engl J Med"},{"key":"1389_CR16","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1002\/ana.21103","volume":"61","author":"MC Dalakas","year":"2007","unstructured":"Dalakas MC, Rakocevic G, Shatunov A, Goldfarb L, Raju R, Salajegheh M (2007) Inclusion body myositis with human immunodeficiency virus infection: four cases with clonal expansion of viral-specific T cells. Ann Neurol 61:466\u2013475. https:\/\/doi.org\/10.1002\/ana.21103","journal-title":"Ann Neurol"},{"key":"1389_CR17","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1017\/s0317167100036684","volume":"13","author":"MJ Danon","year":"1986","unstructured":"Danon MJ, Perurena OH, Ronan S, Manaligod JR (1986) Inclusion body myositis associated with systemic sarcoidosis. Can J Neurol Sci J Can Sci Neurol 13:334\u2013336. https:\/\/doi.org\/10.1017\/s0317167100036684","journal-title":"Can J Neurol Sci J Can Sci Neurol"},{"key":"1389_CR18","doi-asserted-by":"publisher","first-page":"e910","DOI":"10.1212\/WNL.0000000000008863","volume":"94","author":"Y Dieudonn\u00e9","year":"2020","unstructured":"Dieudonn\u00e9 Y, Allenbach Y, Benveniste O, Leonard-Louis S, Hervier B, Mariampillai K, Nespola B, Lannes B, Echaniz-Laguna A, Wendling D, Von Frenckell C, Poursac N, Mortier E, Lavigne C, Hinschberger O, Magnant J, Gottenberg J-E, Geny B, Sibilia J, Meyer A (2020) Granulomatosis-associated myositis: high prevalence of sporadic inclusion body myositis. Neurology 94:e910\u2013e920. https:\/\/doi.org\/10.1212\/WNL.0000000000008863","journal-title":"Neurology"},{"key":"1389_CR19","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1111\/ene.12627","volume":"22","author":"GC Dobloug","year":"2015","unstructured":"Dobloug GC, Antal EA, Sveberg L, Garen T, Bitter H, Stj\u00e4rne J, Gr\u00f8vle L, Gran JT, Molberg \u00d8 (2015) High prevalence of inclusion body myositis in Norway; a population-based clinical epidemiology study. Eur J Neurol 22:672-e41. https:\/\/doi.org\/10.1111\/ene.12627","journal-title":"Eur J Neurol"},{"key":"1389_CR20","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1159\/000314900","volume":"124","author":"G Franco","year":"2010","unstructured":"Franco G, Palazzolo R, Liardo E, Tripodo C, Mancuso S (2010) T cell large granular lymphocytic leukemia in association with Sj\u00f6gren\u2019s syndrome. Acta Haematol 124:5\u20138. https:\/\/doi.org\/10.1159\/000314900","journal-title":"Acta Haematol"},{"key":"1389_CR21","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.semarthrit.2005.07.001","volume":"35","author":"J Friedman","year":"2006","unstructured":"Friedman J, Schattner A, Shvidel L, Berrebi A (2006) Characterization of T-cell large granular lymphocyte leukemia associated with Sjogren\u2019s syndrome-an important but under-recognized association. Semin Arthritis Rheum 35:306\u2013311. https:\/\/doi.org\/10.1016\/j.semarthrit.2005.07.001","journal-title":"Semin Arthritis Rheum"},{"key":"1389_CR22","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1177\/0192623313503519","volume":"42","author":"K Gardner","year":"2014","unstructured":"Gardner K, Hall PA, Chinnery PF, Payne BAI (2014) HIV treatment and associated mitochondrial pathology: review of 25 years of in vitro, animal, and human studies. Toxicol Pathol 42:811\u2013822. https:\/\/doi.org\/10.1177\/0192623313503519","journal-title":"Toxicol Pathol"},{"key":"1389_CR23","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000200013","author":"NA Goyal","year":"2022","unstructured":"Goyal NA, Coulis G, Duarte J, Farahat PK, Mannaa AH, Cauchii J, Irani T, Araujo N, Wang L, Wencel M, Li V, Zhang L, Greenberg SA, Mozaffar T, Villalta SA (2022) Immunophenotyping of inclusion body myositis blood T and NK cells. Neurology. https:\/\/doi.org\/10.1212\/WNL.0000000000200013","journal-title":"Neurology"},{"key":"1389_CR24","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s12979-016-0065-0","volume":"13","author":"BPX Grady","year":"2016","unstructured":"Grady BPX, Nanlohy NM, van Baarle D (2016) HCV monoinfection and HIV\/HCV coinfection enhance T-cell immune senescence in injecting drug users early during infection. Immun Ageing A 13:10. https:\/\/doi.org\/10.1186\/s12979-016-0065-0","journal-title":"Immun Ageing A"},{"key":"1389_CR25","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1038\/s41584-019-0186-x","volume":"15","author":"SA Greenberg","year":"2019","unstructured":"Greenberg SA (2019) Inclusion body myositis: clinical features and pathogenesis. Nat Rev Rheumatol 15:257\u2013272. https:\/\/doi.org\/10.1038\/s41584-019-0186-x","journal-title":"Nat Rev Rheumatol"},{"key":"1389_CR26","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1093\/brain\/aww024","volume":"139","author":"SA Greenberg","year":"2016","unstructured":"Greenberg SA, Pinkus JL, Amato AA, Kristensen T, Dorfman DM (2016) Association of inclusion body myositis with T cell large granular lymphocytic leukaemia. Brain J Neurol 139:1348\u20131360. https:\/\/doi.org\/10.1093\/brain\/aww024","journal-title":"Brain J Neurol"},{"key":"1389_CR27","doi-asserted-by":"publisher","first-page":"2590","DOI":"10.1093\/brain\/awz207","volume":"142","author":"SA Greenberg","year":"2019","unstructured":"Greenberg SA, Pinkus JL, Kong SW, Baecher-Allan C, Amato AA, Dorfman DM (2019) Highly differentiated cytotoxic T cells in inclusion body myositis. Brain 142:2590\u20132604. https:\/\/doi.org\/10.1093\/brain\/awz207","journal-title":"Brain"},{"key":"1389_CR28","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1111\/ijlh.13719","volume":"44","author":"C Gurnari","year":"2022","unstructured":"Gurnari C, Yeaney GA, Kalinowski M, Cotta CV, Maciejewski JP (2022) T-cell large granular lymphocytic leukemia associated with inclusion body myositis. Int J Lab Hematol 44:27\u201328. https:\/\/doi.org\/10.1111\/ijlh.13719","journal-title":"Int J Lab Hematol"},{"key":"1389_CR29","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1002\/ana.24847","volume":"81","author":"A-K G\u00fcttsches","year":"2017","unstructured":"G\u00fcttsches A-K, Brady S, Krause K, Maerkens A, Uszkoreit J, Eisenacher M, Schreiner A, Galozzi S, Mertens-Rill J, Tegenthoff M, Holton JL, Harms MB, Lloyd TE, Vorgerd M, Weihl CC, Marcus K, Kley RA (2017) Proteomics of rimmed vacuoles define new risk allele in inclusion body myositis. Ann Neurol 81:227\u2013239. https:\/\/doi.org\/10.1002\/ana.24847","journal-title":"Ann Neurol"},{"key":"1389_CR30","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/0928-4346(95)00245-6","volume":"4","author":"M Harada","year":"1995","unstructured":"Harada M, Sata M, Yoshida H, Noguchi S, Yamakawa Y, Mimura Y, Ohishi M, Ayabe M, Tanikawa K (1995) Inflammatory myopathy associated with hepatitis C virus infection: a report of four cases. Int Hepatol Commun 4:195\u2013200. https:\/\/doi.org\/10.1016\/0928-4346(95)00245-6","journal-title":"Int Hepatol Commun"},{"key":"1389_CR31","doi-asserted-by":"publisher","DOI":"10.1111\/bpa.12931","volume":"31","author":"C Hedberg-Oldfors","year":"2021","unstructured":"Hedberg-Oldfors C, Lindgren U, Basu S, Visuttijai K, Lindberg C, Falkenberg M, Larsson Lekholm E, Oldfors A (2021) Mitochondrial DNA variants in inclusion body myositis characterized by deep sequencing. Brain Pathol 31:e12931. https:\/\/doi.org\/10.1111\/bpa.12931","journal-title":"Brain Pathol"},{"key":"1389_CR32","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1136\/annrheumdis-2014-206691","volume":"75","author":"MK Herbert","year":"2016","unstructured":"Herbert MK, Stammen-Vogelzangs J, Verbeek MM, Rietveld A, Lundberg IE, Chinoy H, Lamb JA, Cooper RG, Roberts M, Badrising UA, Bleecker JLD, Machado PM, Hanna MG, Plestilova L, Vencovsky J, van Engelen BG, Pruijn GJM (2016) Disease specificity of autoantibodies to cytosolic 5\u2032-nucleotidase 1A in sporadic inclusion body myositis versus known autoimmune diseases. Ann Rheum Dis 75:696\u2013701. https:\/\/doi.org\/10.1136\/annrheumdis-2014-206691","journal-title":"Ann Rheum Dis"},{"key":"1389_CR33","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1093\/jnen\/nlv023","volume":"75","author":"A Hiniker","year":"2016","unstructured":"Hiniker A, Daniels BH, Margeta M (2016) T-Cell-mediated inflammatory myopathies in HIV-positive individuals: a histologic study of 19 cases. J Neuropathol Exp Neurol 75:239\u2013245. https:\/\/doi.org\/10.1093\/jnen\/nlv023","journal-title":"J Neuropathol Exp Neurol"},{"key":"1389_CR34","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.594658","volume":"11","author":"X Hong","year":"2021","unstructured":"Hong X, Meng S, Tang D et al (2021) Single-cell RNA sequencing reveals the expansion of cytotoxic CD4+ T lymphocytes and a landscape of immune cells in primary Sj\u00f6gren's syndrome. Front Immunol 11:594658. https:\/\/doi.org\/10.3389\/fimmu.2020.594658","journal-title":"Front Immunol"},{"key":"1389_CR35","doi-asserted-by":"publisher","first-page":"6088","DOI":"10.4049\/jimmunol.174.10.6088","volume":"174","author":"CC Ibegbu","year":"1950","unstructured":"Ibegbu CC, Xu Y-X, Harris W, Maggio D, Miller JD (1950) Kourtis AP (2005) Expression of killer cell lectin-like receptor G1 on antigen-specific human CD8+ T lymphocytes during active, latent, and resolved infection and its relation with CD57. J Immunol Baltim Md 174:6088\u20136094. https:\/\/doi.org\/10.4049\/jimmunol.174.10.6088","journal-title":"J Immunol Baltim Md"},{"key":"1389_CR36","doi-asserted-by":"publisher","first-page":"e85609","DOI":"10.1172\/jci.insight.85609","volume":"1","author":"ML Joachims","year":"2016","unstructured":"Joachims ML, Leehan KM, Lawrence C, Pelikan RC, Moore JS, Pan Z, Rasmussen A, Radfar L, Lewis DM, Grundahl KM, Kelly JA, Wiley GB, Shugay M, Chudakov DM, Lessard CJ, Stone DU, Scofield RH, Montgomery CG, Sivils KL, Thompson LF, Farris AD (2016) Single-cell analysis of glandular T cell receptors in Sj\u00f6gren\u2019s syndrome. JCI Insight 1:e85609. https:\/\/doi.org\/10.1172\/jci.insight.85609","journal-title":"JCI Insight"},{"key":"1389_CR37","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1093\/rheumatology\/41.4.440","volume":"41","author":"P Kanellopoulos","year":"2002","unstructured":"Kanellopoulos P, Baltoyiannis C, Tzioufas AG (2002) Primary Sj\u00f6gren\u2019s syndrome associated with inclusion body myositis. Rheumatology 41:440\u2013444. https:\/\/doi.org\/10.1093\/rheumatology\/41.4.440","journal-title":"Rheumatology"},{"key":"1389_CR38","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1007\/s13365-018-0647-z","volume":"24","author":"F Kleefeld","year":"2018","unstructured":"Kleefeld F, Heller S, Ingiliz P, Jessen H, Petersen A, Kopp U, Kraft A, Hahn K (2018) Interferon-free therapy in hepatitis C virus (HCV) monoinfected and HCV\/HIV coinfected patients: effect on cognitive function, fatigue, and mental health. J Neurovirol 24:557\u2013569. https:\/\/doi.org\/10.1007\/s13365-018-0647-z","journal-title":"J Neurovirol"},{"key":"1389_CR39","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1002\/cbic.201200731","volume":"14","author":"T Klingstedt","year":"2013","unstructured":"Klingstedt T, Blechschmidt C, Nogalska A, Prokop S, H\u00e4ggqvist B, Danielsson O, Engel WK, Askanas V, Heppner FL, Nilsson KPR (2013) Luminescent conjugated oligothiophenes for sensitive fluorescent assignment of protein inclusion bodies. ChemBioChem 14:607\u2013616. https:\/\/doi.org\/10.1002\/cbic.201200731","journal-title":"ChemBioChem"},{"key":"1389_CR40","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000000558","author":"S Knauss","year":"2019","unstructured":"Knauss S, Preusse C, Allenbach Y, Leonard-Louis S, Touat M, Fischer N, Radbruch H, Mothes R, Matyash V, B\u00f6hmerle W, Endres M, Goebel H-H, Benveniste O, Stenzel W (2019) PD1 pathway in immune-mediated myopathies: pathogenesis of dysfunctional T cells revisited. Neurol - Neuroimmunol Neuroinflamm. https:\/\/doi.org\/10.1212\/NXI.0000000000000558","journal-title":"Neurol - Neuroimmunol Neuroinflamm"},{"key":"1389_CR41","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/1742-4933-5-6","volume":"5","author":"S Koch","year":"2008","unstructured":"Koch S, Larbi A, Derhovanessian E, \u00d6zcelik D, Naumova E, Pawelec G (2008) Multiparameter flow cytometric analysis of CD4 and CD8 T cell subsets in young and old people. Immun Ageing 5:6. https:\/\/doi.org\/10.1186\/1742-4933-5-6","journal-title":"Immun Ageing"},{"key":"1389_CR42","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1136\/jnnp-2018-319419","volume":"90","author":"O Landon-Cardinal","year":"2019","unstructured":"Landon-Cardinal O, Gallay L, Dubourg O, Maisonobe T, L\u00e9onard-Louis S, Beniken D, Simon A, Behin A, Stojkovic T, Duyckaerts C, Breton G, Rigolet A, Fain O, Meyohas M-C, Leport C, Valantin M-A, Vittecoq D, Bergmann J-F, Hanslik T, Chauveheid M-P, Amoura Z, de Broucker T, Eymard B, Beaudequin N, Benveniste O, Allenbach Y (2019) Expanding the spectrum of HIV-associated myopathy. J Neurol Neurosurg Psychiatry 90:1296\u20131298. https:\/\/doi.org\/10.1136\/jnnp-2018-319419","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1389_CR43","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1111\/j.1365-2990.1993.tb00462.x","volume":"19","author":"RJ Lane","year":"1993","unstructured":"Lane RJ, McLean KA, Moss J, Woodrow DF (1993) Myopathy in HIV infection: the role of zidovudine and the significance of tubuloreticular inclusions. Neuropathol Appl Neurobiol 19:406\u2013413. https:\/\/doi.org\/10.1111\/j.1365-2990.1993.tb00462.x","journal-title":"Neuropathol Appl Neurobiol"},{"key":"1389_CR44","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1136\/jnnp.2009.190751","volume":"82","author":"S Larue","year":"2011","unstructured":"Larue S, Maisonobe T, Benveniste O, Chapelon-Abric C, Lidove O, Papo T, Eymard B, Dubourg O (2011) Distal muscle involvement in granulomatous myositis can mimic inclusion body myositis. J Neurol Neurosurg Psychiatry 82:674\u2013677. https:\/\/doi.org\/10.1136\/jnnp.2009.190751","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1389_CR45","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1097\/BOR.0000000000000837","volume":"33","author":"V Leclair","year":"2021","unstructured":"Leclair V, Notarnicola A, Vencovsky J, Lundberg IE (2021) Polymyositis: Does it really exist as a distinct clinical subset? Curr Opin Rheumatol 33:537\u2013543. https:\/\/doi.org\/10.1097\/BOR.0000000000000837","journal-title":"Curr Opin Rheumatol"},{"key":"1389_CR46","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.nmd.2014.12.010","volume":"25","author":"U Lindgren","year":"2015","unstructured":"Lindgren U, Roos S, Hedberg Oldfors C, Moslemi A-R, Lindberg C, Oldfors A (2015) Mitochondrial pathology in inclusion body myositis. Neuromuscul Disord NMD 25:281\u2013288. https:\/\/doi.org\/10.1016\/j.nmd.2014.12.010","journal-title":"Neuromuscul Disord NMD"},{"key":"1389_CR47","doi-asserted-by":"publisher","first-page":"1454","DOI":"10.1212\/WNL.0000000000003821","volume":"88","author":"TE Lloyd","year":"2017","unstructured":"Lloyd TE, Pinal-Fernandez I, Michelle EH, Christopher-Stine L, Pak K, Sacktor N, Mammen AL (2017) Overlapping features of polymyositis and inclusion body myositis in HIV-infected patients. Neurology 88:1454\u20131460. https:\/\/doi.org\/10.1212\/WNL.0000000000003821","journal-title":"Neurology"},{"key":"1389_CR48","doi-asserted-by":"publisher","first-page":"3398","DOI":"10.1093\/rheumatology\/keaa801","volume":"60","author":"J Loarce-Martos","year":"2021","unstructured":"Loarce-Martos J, Lilleker JB, Parker M, McHugh N, Chinoy H (2021) Polymyositis: is there anything left? A retrospective diagnostic review from a tertiary myositis centre. Rheumatology 60:3398\u20133403. https:\/\/doi.org\/10.1093\/rheumatology\/keaa801","journal-title":"Rheumatology"},{"key":"1389_CR49","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2022928118","volume":"118","author":"CJ Lopez Angel","year":"2021","unstructured":"Lopez Angel CJ, Pham EA, Du H, Vallania F, Fram BJ, Perez K, Nguyen T, Rosenberg-Hasson Y, Ahmed A, Dekker CL, Grant PM, Khatri P, Maecker HT, Glenn JS, Davis MM, Furman D (2021) Signatures of immune dysfunction in HIV and HCV infection share features with chronic inflammation in aging and persist after viral reduction or elimination. Proc Natl Acad Sci U S A 118:e2022928118. https:\/\/doi.org\/10.1073\/pnas.2022928118","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1389_CR50","doi-asserted-by":"publisher","first-page":"1955","DOI":"10.1136\/annrheumdis-2017-211468","volume":"76","author":"IE Lundberg","year":"2017","unstructured":"Lundberg IE, Tj\u00e4rnlund A, Bottai M, Werth VP, Pilkington C, de Visser M, Alfredsson L, Amato AA, Barohn RJ, Liang MH, Singh JA, Aggarwal R, Arnardottir S, Chinoy H, Cooper RG, Dank\u00f3 K, Dimachkie MM, Feldman BM, La Torre IG-D, Gordon P, Hayashi T, Katz JD, Kohsaka H, Lachenbruch PA, Lang BA, Li Y, Oddis CV, Olesinska M, Reed AM, Rutkowska-Sak L, Sanner H, Selva-O\u2019Callaghan A, Song YW, Vencovsky J, Ytterberg SR, Miller FW, Rider LG (2017) EULAR\/ACR classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups. Ann Rheum Dis 76:1955\u20131964. https:\/\/doi.org\/10.1136\/annrheumdis-2017-211468","journal-title":"Ann Rheum Dis"},{"key":"1389_CR51","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1038\/nrrheum.2018.41","volume":"14","author":"IE Lundberg","year":"2018","unstructured":"Lundberg IE, de Visser M, Werth VP (2018) Classification of myositis. Nat Rev Rheumatol 14:269\u2013278. https:\/\/doi.org\/10.1038\/nrrheum.2018.41","journal-title":"Nat Rev Rheumatol"},{"key":"1389_CR52","doi-asserted-by":"publisher","first-page":"384","DOI":"10.4161\/auto.4245","volume":"3","author":"JD L\u00fcnemann","year":"2007","unstructured":"L\u00fcnemann JD, Schmidt JC, Dalakas MC, M\u00fcnz C (2007) Macroautophagy as a pathomechanism in sporadic inclusion body myositis. Autophagy 3:384\u2013386. https:\/\/doi.org\/10.4161\/auto.4245","journal-title":"Autophagy"},{"key":"1389_CR53","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000200188.10.1212\/WNL.0000000000200188","author":"AL Mammen","year":"2022","unstructured":"Mammen AL (2022) Inclusion body myositis: An autoimmune or myodegenerative disease? Neurology. https:\/\/doi.org\/10.1212\/WNL.0000000000200188.10.1212\/WNL.0000000000200188","journal-title":"Neurology"},{"key":"1389_CR54","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1097\/nen.0b013e31815f38b7","volume":"67","author":"E Matsuura","year":"2008","unstructured":"Matsuura E, Umehara F, Nose H, Higuchi I, Matsuoka E, Izumi K, Kubota R, Saito M, Izumo S, Arimura K, Osame M (2008) Inclusion body myositis associated with human T-lymphotropic virus-type I infection: eleven patients from an endemic area in Japan. J Neuropathol Exp Neurol 67:41\u201349. https:\/\/doi.org\/10.1097\/nen.0b013e31815f38b7","journal-title":"J Neuropathol Exp Neurol"},{"key":"1389_CR55","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keab716","author":"E Naddaf","year":"2021","unstructured":"Naddaf E, Shelly S, Mandrekar J, Chamberlain AM, Hoffman EM, Ernste FC, Liewluck T (2021) Survival and associated comorbidities in inclusion body myositis. Rheumatology. https:\/\/doi.org\/10.1093\/rheumatology\/keab716","journal-title":"Rheumatology"},{"key":"1389_CR56","first-page":"3","volume":"25","author":"S Naggie","year":"2017","unstructured":"Naggie S (2017) Hepatitis C virus, inflammation, and cellular aging: turning back time. Top Antivir Med 25:3\u20136","journal-title":"Top Antivir Med"},{"key":"1389_CR57","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1136\/jnnp.2007.138891","volume":"79","author":"M Needham","year":"2008","unstructured":"Needham M, James I, Corbett A, Day T, Christiansen F, Phillips B, Mastaglia FL (2008) Sporadic inclusion body myositis: phenotypic variability and influence of HLA-DR3 in a cohort of 57 Australian cases. J Neurol Neurosurg Psychiatry 79:1056\u20131060. https:\/\/doi.org\/10.1136\/jnnp.2007.138891","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1389_CR58","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/j.ebiom.2019.10.034","volume":"49","author":"C Nelke","year":"2019","unstructured":"Nelke C, Dziewas R, Minnerup J, Meuth SG, Ruck T (2019) Skeletal muscle as potential central link between sarcopenia and immune senescence. EBioMedicine 49:381\u2013388. https:\/\/doi.org\/10.1016\/j.ebiom.2019.10.034","journal-title":"EBioMedicine"},{"issue":"10 Supplement","key":"1389_CR59","doi-asserted-by":"crossref","first-page":"P3.288","DOI":"10.1212\/WNL.82.10_supplement.P3.288","volume":"82","author":"A Nogalska","year":"2014","unstructured":"Nogalska A, D\u2019Agostino C, Cacciottolo M, Engel KW, Askanas V (2014) Abnormalities of mitophagy in sporadic inclusion-body myositis (s-IBM) muscle fibers. Neurology 82(10 Supplement):P3.288","journal-title":"Neurology"},{"key":"1389_CR60","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1007\/s00296-019-04314-8","volume":"39","author":"GK Papadimas","year":"2019","unstructured":"Papadimas GK, Kokkinis C, Xirou S, Chrysanthou M, Kararizou E, Papadopoulos C (2019) Polymyositis with mitochondrial pathology or atypical form of sporadic inclusion body myositis: case series and review of the literature. Rheumatol Int 39:1459\u20131466. https:\/\/doi.org\/10.1007\/s00296-019-04314-8","journal-title":"Rheumatol Int"},{"key":"1389_CR61","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1016\/j.autrev.2014.01.017","volume":"13","author":"S Prieto-Gonz\u00e1lez","year":"2014","unstructured":"Prieto-Gonz\u00e1lez S, Grau JM (2014) Diagnosis and classification of granulomatous myositis. Autoimmun Rev 13:372\u2013374. https:\/\/doi.org\/10.1016\/j.autrev.2014.01.017","journal-title":"Autoimmun Rev"},{"key":"1389_CR62","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.3389\/fimmu.2018.01200","volume":"9","author":"A Rietveld","year":"2018","unstructured":"Rietveld A, van den Hoogen LL, Bizzaro N, Blokland SLM, D\u00e4hnrich C, Gottenberg JE, Houen G, Johannsen N, Mandl T, Meyer A, Nielsen CT, Olsson P, van Roon J, Schlumberger W, van Engelen BGM, Saris CGJ, Pruijn GJM (2018) Autoantibodies to cytosolic 5'- nucleotidase 1A in primary Sj\u00f6gren's syndrome and systemic lupus erythematosus. Front Immunol 9:1200. https:\/\/doi.org\/10.3389\/fimmu.2018.01200","journal-title":"Front Immunol"},{"key":"1389_CR63","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1016\/j.clineuro.2011.03.016","volume":"113","author":"A Rojana-udomsart","year":"2011","unstructured":"Rojana-udomsart A, Needham M, Luo YB, Fabian V, Walters S, Zilko PJ, Mastaglia FL (2011) The association of sporadic inclusion body myositis and Sj\u00f6gren\u2019s syndrome in carriers of HLA-DR3 and the 8.1 MHC ancestral haplotype. Clin Neurol Neurosurg 113:559\u2013563. https:\/\/doi.org\/10.1016\/j.clineuro.2011.03.016","journal-title":"Clin Neurol Neurosurg"},{"key":"1389_CR64","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.3389\/fimmu.2019.01040","volume":"10","author":"A Roos","year":"2019","unstructured":"Roos A, Preusse C, Hathazi D, Goebel HH, Stenzel W (2019) Proteomic profiling unravels a key role of specific macrophage subtypes in sporadic inclusion body myositis. Front Immunol 10:1040. https:\/\/doi.org\/10.3389\/fimmu.2019.01040","journal-title":"Front Immunol"},{"key":"1389_CR65","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1016\/j.nmd.2015.06.460","volume":"25","author":"K Sakai","year":"2015","unstructured":"Sakai K, Ikeda Y, Ishida C, Matsumoto Y, Ono K, Iwasa K, Yamada M (2015) Inclusion body myositis with granuloma formation in muscle tissue. Neuromuscul Disord NMD 25:706\u2013712. https:\/\/doi.org\/10.1016\/j.nmd.2015.06.460","journal-title":"Neuromuscul Disord NMD"},{"key":"1389_CR66","doi-asserted-by":"publisher","first-page":"844","DOI":"10.2174\/1389450117666160201112632","volume":"18","author":"C Scagnolari","year":"2017","unstructured":"Scagnolari C, Monteleone K, Cacciotti G, Antonelli G (2017) Role of interferons in chronic hepatitis C infection. Curr Drug Targets 18:844\u2013850. https:\/\/doi.org\/10.2174\/1389450117666160201112632","journal-title":"Curr Drug Targets"},{"key":"1389_CR67","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1111\/j.1365-2567.2011.03470.x","volume":"134","author":"M Strioga","year":"2011","unstructured":"Strioga M, Pasukoniene V, Characiejus D (2011) CD8+ CD28- and CD8+ CD57+ T cells and their role in health and disease. Immunology 134:17\u201332. https:\/\/doi.org\/10.1111\/j.1365-2567.2011.03470.x","journal-title":"Immunology"},{"key":"1389_CR68","doi-asserted-by":"crossref","first-page":"49.9","DOI":"10.4049\/jimmunol.200.Supp.49.9","volume":"200","author":"A Tata","year":"2018","unstructured":"Tata A, Brossay L (2018) Role of the KLRG1 pathway in the immune response. J Immunol 200:49.9-49.9","journal-title":"J Immunol"},{"key":"1389_CR69","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1002\/ana.24919","volume":"81","author":"N Tawara","year":"2017","unstructured":"Tawara N, Yamashita S, Zhang X, Korogi M, Zhang Z, Doki T, Matsuo Y, Nakane S, Maeda Y, Sugie K, Suzuki N, Aoki M, Ando Y (2017) Pathomechanisms of anti\u2013cytosolic 5\u2032-nucleotidase 1A autoantibodies in sporadic inclusion body myositis. Ann Neurol 81:512\u2013525. https:\/\/doi.org\/10.1002\/ana.24919","journal-title":"Ann Neurol"},{"key":"1389_CR70","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.jns.2008.11.010","volume":"278","author":"P Temiz","year":"2009","unstructured":"Temiz P, Weihl CC, Pestronk A (2009) Inflammatory myopathies with mitochondrial pathology and protein aggregates. J Neurol Sci 278:25\u201329. https:\/\/doi.org\/10.1016\/j.jns.2008.11.010","journal-title":"J Neurol Sci"},{"key":"1389_CR71","first-page":"370","volume":"92","author":"Y Tsuruta","year":"2001","unstructured":"Tsuruta Y, Yamada T, Yoshimura T, Satake M, Ogata K, Yamamoto T, Furuya H, Kira J (2001) Inclusion body myositis associated with hepatitis C virus infection. Fukuoka Igaku Zasshi Hukuoka Acta Medica 92:370\u2013376","journal-title":"Fukuoka Igaku Zasshi Hukuoka Acta Medica"},{"key":"1389_CR72","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1212\/WNL.0000000000002291","volume":"86","author":"A Uruha","year":"2016","unstructured":"Uruha A, Noguchi S, Hayashi YK, Tsuburaya RS, Yonekawa T, Nonaka I, Nishino I (2016) Hepatitis C virus infection in inclusion body myositis: a case-control study. Neurology 86:211\u2013217. https:\/\/doi.org\/10.1212\/WNL.0000000000002291","journal-title":"Neurology"},{"key":"1389_CR73","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1093\/rheumatology\/ken252","volume":"47","author":"G Vattemi","year":"2008","unstructured":"Vattemi G, Tonin P, Marini M, Guadagnin ML, Dal Pra B, Simonati A, Filosto M, Tomelleri G (2008) Sarcoidosis and inclusion body myositis. Rheumatology 47:1433\u20131435. https:\/\/doi.org\/10.1093\/rheumatology\/ken252","journal-title":"Rheumatology"},{"key":"1389_CR74","doi-asserted-by":"publisher","first-page":"3003","DOI":"10.1093\/rheumatology\/keaa012","volume":"59","author":"X Wang","year":"2020","unstructured":"Wang X, Bootsma H, Terpstra J, Vissink A, van der Vegt B, Spijkervet FKL, Kroese FGM, Pringle S (2020) Progenitor cell niche senescence reflects pathology of the parotid salivary gland in primary Sj\u00f6gren\u2019s syndrome. Rheumatology 59:3003\u20133013. https:\/\/doi.org\/10.1093\/rheumatology\/keaa012","journal-title":"Rheumatology"},{"key":"1389_CR75","doi-asserted-by":"publisher","first-page":"2143","DOI":"10.4049\/jimmunol.1301721","volume":"192","author":"AM Wertheimer","year":"2014","unstructured":"Wertheimer AM, Bennett MS, Park B, Uhrlaub JL, Martinez C, Pulko V, Currier NL, Nikolich-\u017dugich D, Kaye J, Nikolich-\u017dugich J (2014) Aging and cytomegalovirus infection differentially and jointly affect distinct circulating T Cell subsets in humans. J Immunol 192:2143\u20132155. https:\/\/doi.org\/10.4049\/jimmunol.1301721","journal-title":"J Immunol"},{"key":"1389_CR76","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1016\/j.immuni.2007.09.006","volume":"27","author":"EJ Wherry","year":"2007","unstructured":"Wherry EJ, Ha S-J, Kaech SM, Haining WN, Sarkar S, Kalia V, Subramaniam S, Blattman JN, Barber DL, Ahmed R (2007) Molecular signature of CD8+ T cell exhaustion during chronic viral infection. Immunity 27:670\u2013684. https:\/\/doi.org\/10.1016\/j.immuni.2007.09.006","journal-title":"Immunity"},{"key":"1389_CR77","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1093\/jnen\/nlab101","volume":"80","author":"M Winkler","year":"2021","unstructured":"Winkler M, von Landenberg C, Kappes-Horn K, Neudecker S, Kornblum C, Reimann J (2021) Diagnosis and clinical development of sporadic inclusion body myositis and polymyositis with mitochondrial pathology: a single-center retrospective analysis. J Neuropathol Exp Neurol 80:1060\u20131067. https:\/\/doi.org\/10.1093\/jnen\/nlab101","journal-title":"J Neuropathol Exp Neurol"},{"key":"1389_CR78","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1038\/s41586-021-03547-7","volume":"594","author":"MJ Yousefzadeh","year":"2021","unstructured":"Yousefzadeh MJ, Flores RR, Zhu Y, Schmiechen ZC, Brooks RW, Trussoni CE, Cui Y, Angelini L, Lee K-A, McGowan SJ, Burrack AL, Wang D, Dong Q, Lu A, Sano T, O\u2019Kelly RD, McGuckian CA, Kato JI, Bank MP, Wade EA, Pillai SPS, Klug J, Ladiges WC, Burd CE, Lewis SE, LaRusso NF, Vo NV, Wang Y, Kelley EE, Huard J, Stromnes IM, Robbins PD, Niedernhofer LJ (2021) An aged immune system drives senescence and ageing of solid organs. Nature 594:100\u2013105. https:\/\/doi.org\/10.1038\/s41586-021-03547-7","journal-title":"Nature"},{"key":"1389_CR79","unstructured":"Single Cell Analysis of TCRs from CD8+ T Cells in Sjogren\u2019s Syndrome. In: ACR Meet. Abstr. https:\/\/acrabstracts.org\/abstract\/single-cell-analysis-of-tcrs-from-cd8-t-cells-in-sjogrens-syndrome\/. Accessed 27 Mar 2022"},{"key":"1389_CR80","doi-asserted-by":"publisher","unstructured":"Major features of immunesenescence, including reduced thymic output, are ameliorated by high levels of physical activity in adulthood - Duggal - 2018 - Aging Cell - Wiley Online Library. https:\/\/onlinelibrary.wiley.com\/doi\/full\/https:\/\/doi.org\/10.1111\/acel.12750. Accessed 27 Mar 2022","DOI":"10.1111\/acel.12750"}],"container-title":["Acta Neuropathologica Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40478-022-01389-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40478-022-01389-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40478-022-01389-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,26]],"date-time":"2024-09-26T07:11:15Z","timestamp":1727334675000},"score":1,"resource":{"primary":{"URL":"https:\/\/actaneurocomms.biomedcentral.com\/articles\/10.1186\/s40478-022-01389-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,3]]},"references-count":80,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["1389"],"URL":"https:\/\/doi.org\/10.1186\/s40478-022-01389-6","relation":{},"ISSN":["2051-5960"],"issn-type":[{"value":"2051-5960","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,3]]},"assertion":[{"value":"24 May 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 May 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 June 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"The authors report no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"84"}}